LIFR alpha Antibody (32953) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB249C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 32953
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human LIF R alpha
Gln45-Ser833
Accession # P42702
Gln45-Ser833
Accession # P42702
Specificity
Detects human LIF R alpha in direct ELISAs and Western blots.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for LIFR alpha Antibody (32953) [PerCP]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from ascites
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LIFR alpha
Long Name
Leukemia Inhibitory Factor Receptor alpha
Alternate Names
CD118, LIF R alpha, LIF R beta, LIFR, LIFRa
Gene Symbol
LIFR
Additional LIFR alpha Products
Product Documents for LIFR alpha Antibody (32953) [PerCP]
Product Specific Notices for LIFR alpha Antibody (32953) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...